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On  the  basis  of studies  with  immunoadsorbent columns,  many  soluble, 
lymphocyte-derived,  helper and suppressor factors, which mediate T-cell B-cell 
macrophage interaction during antibody synthesis, have been shown to consist 
of H-2-1inked I-region associated (Ia)  1 antigens  (1-3). It has been postulated 
that/-region genes also determine the putative receptors for both helper (4-6) 
and suppressor (7-10) factors. Both helper factors and their receptors have been 
reported to be controlled by the I-A subregion (4, 5, 10). Suppressor cell factors 
and their receptors have been found to be products of either the I-J subregion 
(7,  10) or the I-C subregion (9). 
We have previously demonstrated that an antigen-nonspecific helper factor, 
allogeneic effect factor (AEF), is comprised of Ia antigens derived from both the 
activated responder and irradiated stimulator spleen cells of a  mixed lympho- 
cyte culture reaction (MLR) (11). This AEF helped a  primary and secondary 
antibody response of both T-cell-depleted responder spleen B cells and stimula- 
tor spleen B cells. Identity in the I-A and/or  I-B subregions was required for the 
interaction between this AEF and primary (nonimmune) spleen B cells. 
An AEF produced by Ia-negative activated responder cells and irradiated T- 
cell-depleted stimulator cells helped a  secondary antibody response of T-cell- 
depleted stimulator B  cells  but  not responder B  cells  (12). This  genetically 
restricted AEF was shown to contain Ia antigens determined by the stimulator 
haplotype but not the responder haplotype. These observations indicated that 
restricted AEF is the product of a stimulator B cell and/or macrophage. 
In this report, we show that restricted AEF is a B-cell-derived helper factor 
which consists in part of active Ia antigen components determined by the I-A 
subregion. We also demonstrate that restricted AEF possesses a target B-cell 
receptor which may also be controlled by the/-A subregion. Taken together, 
the  data  suggest that  the H-2  restriction in  the  activity of restricted AEF 
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TABLE  I 
H-2  Haplotype  Origin  of Strains  Used 
Strain  Haplotype 
Region* 
I 
K  A  B  J  E  C  S  G  D 
B10.A  a  k  k  k  k  k  kids  d  d  d 
B10.BR  k  k  k  k  k  k  k  k  k  k 
B10.S  s  s  s  s  s  s  s  s  s  s 
A.TL  tl  s  k  k  k  k  k  k  k  d 
A.TH, B10.S(7R)  t2  s  s  s  s  s  s  s  s  d 
B10.HTT  t3  s  s  s  s  k  k  k  k  d 
B10.S(gR)  t4  s  s  ?  k  k  d  d  d  d 
A.TFR5  ap5  f  f  f  f  f  k  k  k  d 
* Haplotype origin  of  H-2 regions according to references  21 and 39. 
It  is  not  yet  certain  whether the  I-C subregion of  the  H-2  a haplotype is  derived from the  H-2  ~  or 
H-2  ~ haplotype. 
during B-cell  activation  is  mediated, in  part,  by a recognition  of  complementar- 
ity between la antigens in this  factor  and/-region products in its receptor.  A 
preliminary report of some of the data included here has been previously 
published (13). 
Materials and Methods 
Mice.  All inbred strains of mice used in this study were  maintained in  our colony  at the 
University of Toronto. These strains were derived from breeding pairs kindly supplied by Doctors 
H.  O.  McDevitt,  Stanford  University,  Stanford,  Calif.,  and  D.  C.  Schreffler,  Washington 
University, St.  Louis, Mo. 
Antisera.  The antisera used in these studies and the respective H.2  regions or subregious 
immunized against are as  follows:  A.TH anti-A.TL (anti-/~,  S  ~,  Gk);  A.TL anti-A.TH (anti-I  s,  S', 
G');  (B10.A × A.TL)FI anti-B10.S(9R) (anti-I-A% I-B'?);  (B10.A × A.TL)FI anti-B10.HTT (anti-I- 
A s,  I-B',  I-J  m) B10.HTT anti-B10.S(7R) (anti-I-EL  I-C',  S', G');  and (B10.HTT × A.TFR5)FI anti- 
A.TH (anti-l-E  s,  I-C  s,  S  s, Gs).  The latter  three sera were a kind gift  from Doctors D. B. Murphy 
and H. O. McDevitt, Stanford University, Stanford, Calif.  All of  the above sera were raised by 
hyperimmunization of recipient  mice with donor spleen and lymph node lympbocytes as previ- 
ously described (14).  An AKR/J anti-AKR/Cum  anti-Thy-l.2 serum, produced by using donor 
thymocytes and spleen cells  for immunization, was used to deplete spleen cell  suspensions of  T 
cells.  The 1-1-2  haplotypes of  some of  the strains  used in this  study are shown in Table I. 
Antigens and Immunizations.  The preparation of  the  2,4-dinitrophenyl  (DNP) keyhole limpet 
hemocyanin (KLH; Calbiochem, Downsview, Ontario) conjugate, DNPH-KLH  (per  105 daltons), 
and the immunization of  mice with this  antigen were performed as  previously reported (12).  Mice 
were sacrificed  4-8 wk postimmunization and were used as primed spleen cell  donors. 
Preparation  of Restricted  AEF.  Restricted AEF  was prepared as previously  described  (12). 
Briefly, as shown in Fig. 1, B10.BR(H-2  ~) lymphocytes were allogeneically activated against H-2  s 
antigens by the intravenous injection of irradiated (800 rads) B10. S (H-2  s) recipients with 1-1.5  × 
108 B10.BR donor thymocytes. 5 days later, the activated responder B10.BR cells were harvested 
from the stimulator B10.S recipients. Ia-negative respender cells were prepared by treatment of 
108 cells with I ml of A.TH anti-A.TL diluted 1:5 for 20 rain at room temperature. Cells were then 
centrifuged  and  resuspended  in  3  ml  of agarose-adsorbed  rabbit complement  diluted  1:9  and 
incubated for a further 45 min at 37°C,  centrifuged, washed twice, and resuspended in serum-free 
Click's medium (15) supplemented with 4 mM glutamine and 5 × 10 -5 M 2-mercaptoethanol before 1200  /-REGION  CONTROL  OF  B-CELL  ACTIVATION 
Production of Restricted AEF 
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$  5 days 
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-treated with anti la  k and complement 
Mixed with 
Irradiated Stimulator Cells (B10.S) 
-treated with anti-Thy 1.2 and complement 
Fro.  1.  Production of restricted AEF. 
culture. T-cell-depleted  (<3% T cells,  [12])  normal stimulator B10.S cells  were similarly  prepared 
by treatment with anti-Thy-1.2 (AKR/J anti-AKR/Cum)  and rabbit  complement. Restricted  AEF 
was prepared by collection  of supernates  from 16-24 h MLR  cultures between 107 Is-negative 
activated  responder BI0.BR cells  and 107  normal irradiated  (3,000  rads)  T-cell-depleted  stimulator 
B10.S spleen cells.  Culture conditions and medium were the same as reported earlier  (12). 
Immunoadsorption and Assay of Restricted AEF Activity.  The methods used for the immu- 
noadsorption on antibody-coated columns and assay of restricted AEF activity were previously 
described (12). The adsorption of restricted AEF activity was carried out during a 1 h incubation 
at 4°C on immunoadsorbents each consisting of approximately 5 mg of the IgG fraction a given 
mouse anti-Ia serum coupled to 1 g of cyanogen-bromide-activated Sepharose 4B (Pharmaeia Fine 
Chemicals Inc.,  Dorval, Quebec).  The activities of various column effluent fractions were then 
tested. 
The cellular expression of a receptor for restricted AEF was analyzed by adsorption (9) of its 
activity by various cell types. All cell suspensions were prepared in serum-free Click's medium 
and were washed twice with this medium before adsorption. They were shown to contain greater 
than 90% viable cells as judged by trypan blue dye exclusion. The adsorbing cells used, derived 
from normal unprimed B10.S donors,  were thymocytes, lymph node cells, spleen cells, spleen T 
cells prepared by passage through a nylon wool column (16), T-cell.depleted spleen cells prepared 
by  treatment with anti-Thy-l.2 plus complement, Is-negative T-cell-depleted spleen cells, and 
macrophage-depleted T-cell-depleted spleen cells (prepared as outlined in the section below). To 
prepare Ia-negative T-cell-depleted spleen cells, approximately 7.5 × 107 T-coll-depletod  cells were 
washed twice, fractionated on a  1 g fetal calf serum  (FCS)  gradient to remove dead cells (17), 
washed twice in serum-free medium, treated with anti-Ia serum plus complement (see  above), 
washed  twice, and then used for adsorption.  Approximately 107 cells were recovered from the 
original T-cell-depleted spleen c~ll population after this treatment.  1 ml of restricted AEF was 
incubated in undiluted form with 0.1-1.0  x  108 adsorbing cells in serum-free Click's medium at 
4°C for 30 min with occasional mixing. After centrifugation of  the cells, the activity of nonadsorbed 
AEF in the supernates was tested. 
The helper activity of either unadsorbed or adsorbed (as above) restricted AEF was assayed in 
an in vitro secondary anti-DNP plaque-forming cell (PFC) response of DNPI1-KLH primed T-cell- 
depleted B10.S spleen coils after a 6 day culture in Click's medium containing 5% heat-inactivated 
FCS  (Click-FCS).  Anti-DNP indirect  (IgG)  PFC  were evaluated in  triplicate  0.3-ml  cultures, 
containing  106  spleen  cells,  by  the  Cunningham  and  Szenberg  method  (18) by  using  2,4,6- 
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Depletion of Macrophages from Spleen Cell Suspensions.  The phagocytic cells present in a T- 
cell-depleted spleen cell population were removed by the carbonyl-iron technique as previously 
reported  (19).  To  a  suspension of cells at  20  ×  106/ml in  Click-FCS  was  added  powdered  iron 
(Fisher Scientific Co.,  Don Mills, Ontario) at a  concentration of 50 mg/ml. This suspension was 
incubated for I  rain at 37°C,  then layered over an equal vol (5 ml) of Ficoll-Hypaque (Pharmacia 
Fine Chemicals, Inc.,  Dorval, Quebec and Winthrop Laboratories, Aurora, Ontario) and centri- 
fuged at 450 g  for 45 min. The cells banding at the Click-Ficoll interface were aspirated with a 
Pasteur  pipette  and  washed twice  with  serum-free  Click's  medium  before  use.  The  extent of 
contamination  with  monocytes  and/or  granulocytes  was  determined  cytochemically  by  the 
nonspecific esterase (NSE) staining method of Yam et al.  (20). 
Application of this technique to T-depleted spleen cells reduced the percentage of NSE-stained 
cells  from  approximately  5%  to  less  than  1%.  Thus,  the  technique  was  adopted  to  remove 
macrophages from T-depleted spleen cells used for the stimulator cell population in an MLR to 
generate restricted AEF and for the cellular adsorption of restricted AEF activity. 
Results 
I-Region  Control  of Restricted  AEF Activity.  By  the  use  of appropriate 
immunoadsorbents,  restricted  AEF  was  previously  shown  to  consist  of Ia 
antigens  derived  only  from  the  stimulator  (H-29  and  not  responder  (H-2  k) 
haplotype (12). The anti-Ia antiserum used for adsorption was A.TL anti-A.TH 
(anti-/',  S',  G'),  which potentially contains antibody activity against  determi- 
nants of the entire/-region.  It was therefore of interest to ascertain whether a 
specific/'-subregion (s) codes for the Ia antigens present in restricted AEF. 
Restricted  AEF  was  fractionated  on  immunoadsorbents  conjugated  with 
either A.TL anti-A.TH (anti-I', S', G'), (B10.A x  A.TL)F1 anti-B10.S(9R) (anti- 
I-A',  I-B'?),  (B10.A  ×  A.TL)F1  anti-B10.HTT  (anti-I-A',  I-B s, I-J'),  B10.HTT 
anti-B10.S(7R)  (anti-I-E',  I-C',  S',  G'),  or  (B10.HTT  x  A.TFR5)F1  anti-A.TH 
(anti-I-E', I-C', S', G'). The activity of the column effluents of AEF was tested 
at a final concentration of 25% in a secondary anti-DNP PFC response of B10.S 
primed  spleen  B  cells.  Both  this  concentration  and  a  50%  concentration  of 
restricted AEF yield an optimum response under the conditions used here. Fig. 
2 shows that AEF activity was adsorbed by antisera reactive with determinants 
of either the entire I' subregion or only the I-A" and I-B" subregions and not the 
I-E" and I-C" subregions. The data suggest that restricted AEF Ia antigens are 
determined by the I-A  and/or I-B subregion.  However, it should be noted that 
the failure of the anti-I-E',  I-C', S', G" sera to adsorb restricted AEF activity 
may be accounted for by their rather weak cytotoxic antibody activity against 
B10.S lymph node target cells (approximately 15% specific cytotoxicity, titer = 
1:10).  By  contrast,  about  50-60%  of  B10.S  lymph  node  target  cells  were 
specifically lysed by the sera containing anti-I-A', I-B'? (titer =  1:320) and anti- 
I-A', I-B', I-J" (titer  =  1:160) reactivity (T.  L. Delovitch, unpublished observa- 
tions).  Accordingly,  the control of restricted  AEF Ia antigens  by the I-E  and 
I-C subregions may not be ruled out. 
B-Cell  Origin of Restricted AEF.  We have  previously suggested  that  re- 
stricted  AEF  Ia  antigens  are  the  products  of a  B  cell  and/or  macrophage. 
However,  the  precise  cellular  origin  of restricted  AEF  was  not  identified. 
Therefore, we have now analyzed the activity of a restricted AEF derived from 
Ia-negative  responder  cells  and  irradiated,  T-cell-depleted,  macrophage-de- 
pleted  stimulator  spleen  cells.  This  stimulator  cell population  contained  less 1202  /-REGION  CONTROL  OF  B-CELL  ACTIVATION 
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FIG.  2.  Mapping of restricted AEF activity.  Untreated and  anti-Thy-l.2-treated DNP- 
KLH primed B10.S spleen cells were cultured with (+) or without (-) DNP-KLH (1 ng/ml) 
in the absence or presence of either unadsorbed or antibody column adsorbed restricted 
AEF (25% final concentration). The antisera and method used for the preparation of the 
immunoadsorbents  are described in Materials and Methods. Indirect PFC in triplicate 6-day 
cultures  in  Click-FCS medium were enumerated by  using TNP-coupled burro  RBC  as 
indicator cells. Direct PFC values ranged from 100 to 200/107 cultured cells and are not 
shown here. The results obtained from two experiments are presented as standard errors 
of the geometric mean. 
than 1% esterase-positive cells and was thus considered to be essentially devoid 
of macrophages (see Materials and Methods). Fig. 3 shows that such a restricted 
AEF,  when  tested  at  a  concentration  of 50%,  helped  a  secondary  anti-DNP 
response of hapten-primed,  macrophage-depleted T-cell-depleted spleen cells of 
stimulator B10.S origin but not responder B10.BR origin. 
Thus,  this restricted  AEF displays a  haplotype preference identical  to that 
obtained  by using  Ia-negative  responder  cells  and  irradiated,  T-cell-depleted 
stimulator spleen cells (12).  More significantly, the presence of macrophages in 
the stimulator cell population does not seem to be required for the production of 
an active AEF.  This result,  taken together with the data presented in Fig.  2, 
suggests that restricted AEF Ia antigens are B-cell-derived products of the I-A 
and possibly I-B subregions. 
I-Region Control of a Receptor for Restricted AEF.  Genetic analysis of the 
activity  of several  factors  with  their  appropriate  target  cells,  derived  from 
various/-region  recombinant-inbred  strains,  has  previously  demonstrated  a 
requirement  for/-subregion  identity between the factor-producing  and target 
cell strains  (4-9).  In this study,  we examined the ability of a  restricted AEF, 
produced  as  mentioned  in  the  previous  section,  to  help  B  cells  from  various 
strains  in  a  secondary response  (Fig.  3).  This  AEF  helped  not only  B10.S B 
cells, but also B10.HTT, B10.S(9R) and A.TH B cells. No response was obtained 
with A.TL B cells. TERRY  L.  DELOVITCH,  JUDITH  BIGGIN,  AND  FOON-YEE 
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Fro.  3.  Strain distribution analysis of restricted AEF activity. The activity of restricted 
AEF was assayed at a  50%  concentration with primed,  macrophage-depleted,  anti-Thy- 
1.2-treated cells of various strains. The responses of untreated primed cells were included as 
controls.  Culture conditions and evaluation of PFC are as in Fig. 2.  The results  of three 
experiments are shown. 
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Thus,  restricted AEF activity  is dependent upon/-region  identity between 
the AEF producing strain (B10.S) and its selected target cell strain. The data 
also  suggest that  macrophage-depleted,  T-cell-depleted hapten-primed  spleen 
cells derived from B10.S, B10.HTT, B10.S(gR), and A.TH express a receptor for 
restricted AEF. By reference to the H-2 haplotypes of  origin of  the strains tested 1204 
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FIG.  4.  Cellular adsorption of restricted AEF activity. The activity of restricted AEF was 
assayed  at  a  concentration of 25%  with  DNP-KLH  primed  anti-Thy-l.2-treated B10.S 
spleen cells either before or after adsorption. 108 normal B10.S spleen cells, spleen Thy-l.2- 
(T-cell depleted) cells,  spleen T  cells  (nylon wool  nonadherent),  lymph node  cells,  and 
thymus cells were used for adsorption. Culture  conditions, number of experiments, and 
evaluation of PFC are as in Fig. 3. 
(Table  I),  it is evident that this putative receptor is controlled by H-2-1inked 
genes which map to the lei~ of the I-J subregion. The result obtained with A.TL 
cells  implies  that  the K-region  is  not  involved  here.  It  may be  concluded, 
therefore, that the receptor for restricted AEF is a product of the I-A and/or I-B 
subregion. 
Cellular Expression  of a  Receptor for Restricted AEF.  The observation of 
cellular adsorption of the activity of a soluble lymphocyte-derived MLR suppres- 
sor factor has suggested the presence of a receptor for this factor on an activated 
T  lymphocyte (9). The  above  strain  distribution  analysis of restricted  AEF 
activity suggested that  hapten-primed,  macrophage-depleted,  T-cell-depleted 
spleen B cells of several strains express a receptor for restricted AEF. However, 
no indication of whether this receptor can be found on T cells and macrophages, 
in addition to B cells, was presented. We therefore used the cellular adsorption 
technique in an attempt to identify the cell type(s) which expresses a receptor 
for restricted AEF. 
Preliminary  experiments  demonstrated  that  restricted  AEF  activity  was 
completely removed by adsorption on B10. S T-cell-depleted spleen cells obtained 
from  either  antigen-primed  or  normal  (nonimmune)  donors.  Since  normal 
donors were available in larger amount and also more frequently, all further 
adsorption studies were conducted with cells from normal B10.S  mice. These 
experiments were performed with a  restricted AEF prepared  as  described in 
Fig. 1. Fig. 4 shows that l0  s spleen cells, T-cell-depleted spleen cells, and lymph 
node cells each adsorbed AEF activity. Complete adsorption was achieved by 
the  spleen  cell  populations,  while  approximately  only  50%  adsorption  was 
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number of B cells in these cell populations. It should be noted that a minimum 
of approximately 5  ×  10  7 B-cell-enriched T-depleted spleen cells were required 
for complete adsorption (T.  Delovitch, J. Biggin, and F-Y.  Fung,  unpublished 
observation). By contrast, l0  s nylon wool-purified spleen T cells (2% Ig-positive) 
and thymocytes showed little or no adsorbing capacity. Prior activation of the 
latter two cell populations with concanavalin A failed to result in their adsorp- 
tion of AEF activity (data not shown). Similar data were obtained from these 
various cell suspensions prepared from nonimmune B10.HTT  donors but not 
from B10.BR or B10 donors (T.  Delovitch, J.  Biggin,  and F-Y.  Fung,  unpub- 
lished observations). 
These studies,  along with those presented in Fig. 3, indicate that restricted 
AEF potentiates an antibody response of B cells derived only from strains which 
possess  a  receptor for this  helper factor.  They also  imply that  B  cells,  and 
perhaps  macrophages, bear this receptor. In addition,  it  may be argued that 
some residual T cells in the T-cell-depleted spleen cell population adsorbed AEF 
activity and therefore also bear this receptor. However, this is unlikely for two 
reasons.  First,  this  cell  suspension  contained  less  than  3%  Thy-l.2-positive 
cells, as assayed by cytotoxicity by using the same AKR/J anti-AKR/Cum anti- 
Thy-l.2 serum originally employed for the depletion of T cells. Second, as noted 
above, no adsorption was observed with 10  s nylon wool purified spleen cells. 
To  further examine the cellular origin of this  receptor,  a  comparison was 
made between the adsorbing capacity of B10.S T-cell-depleted spleen cells and 
macrophage-depleted,  T-cell-depleted spleen  cells,  l0  s  T-cell-depleted  spleen 
cells and 8 ×  10  7 macrophage-depleted, T-cell-depleted spleen cells, which were 
recovered aider removal of phagocytic cells fromthe original 10  s T-cell-depleted 
cells in the suspension,  were used. As may be seen in Fig.  5,  both these cell 
populations adsorbed virtually all of the activity of restricted AEF. Removal of 
macrophages from a  T-cell-depleted spleen cell suspension does not reduce the 
adsorption capacity of the latter cell population.  Moreover, no adsorption was 
obtained with 9 × 10  7 splenic adherent cells (adherent to plastic, see reference 6 
for details), while an equivalent number of splenic non-adherent cells removed 
all AEF activity (data not shown). Hence, it is clear that B cells, but neither 
macrophages nor T cells, bear a receptor for AEF. It is also evident from Fig. 5 
that the adsorbing capacity of T-cell-depleted spleen cells may be eliminated by 
pretreatment of this cell suspension with either A.TL anti-A.TH  (anti-/', S', 
G') or (B10.A  ×  A.TL)F1 anti-B10.S(9R)  (anti-I-A', I-B'?) and complement. In 
each instance,  only about  10  7 of the original  l0  s cells in  the  T-cell-depleted 
spleen  cell  suspension  survived  treatment  with  these  sera.  These  findings 
therefore demonstrate that those B cells which possess a receptor for restricted 
AEF also bear surface Ia antigens. Furthermore, since nonimmune B cells were 
used for these adsorption studies,  B  cells need not be activated by antigen to 
induce the expression of this receptor. 
Discussion 
Further evidence is provided here for a regulatory role of Ia antigens in the 
activation of B cells to IgG antibody production. Ia antigens determined by the 
stimulator haplotype have been shown to be active components of restricted 
AEF (12). The control of these Ia determinants has now been localized to the I- 1206 
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Fro.  5.  Expression  of a  receptor  for  restricted  Ale.F by  Ia-positive  spleen B  cells.  The 
activity of restricted AEF  was assayed as in Fig. 4 at a concentration of 25%  after 
adsorption on either 108 spleen Thy-1.2- (T-cell-depleted)  cells,  8 × 107 macrophage (ms)- 
depleted spleen Thy-l.2- cells,  or 107 spleen Thy-l.2- cells  that survived lysis  by either 
A.TL anti-A.TH(anti-l', S', G') or (B10.A × A.TL)FI anti-B10.S(gR) (anti-I-A',  I-B,?) plus 
complement (la-negative,  T-cell-depleted  cells).  Culture conditions,  number of  experiments 
and evaluation of  PFC are as in Fig. 3. 
A  and/or  I-B  subregions.  It  is  possible  that  the  I-B  subregion  may  not  be 
involved here. Since the H-2 haplotype origin of the I-B subregion of B10.S(gR) 
has not yet been identified (21), it is not certain whether the (B10.A × A.TL)F1 
anti-B10.S(gR)  (anti-I-A',  I-B'?)  serum used to adsorb restricted  AEF activity 
detects  a  product  of the  I-B'  subregion.  Moreover,  none  of the  known  Ia 
specificities have been mapped to the I-B" subregion  (21).  An antibody which 
reacts  with  only  an  /-A'  subregion  product  may  therefore  be  sufficient  to 
completely  adsorb  this  activity.  It  should  also  be  cautioned,  however,  that 
additional control here by the/-E s and I-C' subregions cannot yet be excluded. 
No Ia specificities have as yet been localized to these I  subregions (21).  Several 
investigators have therefore found it difficult to produce high-titered  cytotoxic 
antibody reactive with products of these particular I  subregions. Consequently, 
the latter findings may explain why the sera containing potential anti-I-E', I-C" 
reactivity did not adsorb any restricted AEF activity. While these mapping data 
are  presently  somewhat  inconclusive,  the  findings  that  restricted  AEF  is 
definitely a product of the I-A subregion is compatible with reports that several 
other helper factors are also determined by this subregion (4, 5,  10). 
Data presented  here indicate that  restricted  AEF may be a  B-cell product. 
The  depletion  of macrophages  from  the  stimulator  cell  population  used  to 
produce restricted AEF does not reduce AEF helper activity. Similarly, Eshhar 
et al.  (22) found that the removal of adherent  cells from either the responder 
cells or the stimulator  cells does not abrogate any of the helper  activity of a 
nonrestricted  AEF.  Moreover,  these  investigators  reported  that  this  nonres- 
tricted AEF possesses components derived from the stimulator cell population, 
as  well  as  the  responder  cell  population.  This  observation  confirmed  our TERRY  L.  DELOVITCH,  JUDITH  BIGGIN,  AND  FOON-YEE  FUNG  1207 
previous findings (12). It may, therefore be concluded that macrophages do not 
produce AEF,  nor  are they required to  be present  for its  production.  These 
conclusions agree with those previously reported for a  T cell replacing factor 
present in an allogeneic supernate  (23). Nevertheless, it should be cautioned 
that the T-cell-depleted, macrophage-depleted, stimulator cell population used 
here to generate restricted AEF may still contain a  nondetectable number of 
functional  macrophages.  In  this  report,  macrophage depletion  was  assayed 
solely  by  the  ability  to  remove  esterase-positive  cells.  However,  a  small 
subpopulation  of esterase-negative  macrophages  which  readily  phagocytose 
latex  particles  can  mediate  a  primary  IgM  anti-hapten  PFC  response  (C. 
Cowing, Immunology Branch, National Institutes of Health, personal commu- 
nication).  It  is  not  known  whether this  macrophage subpopulation  bears  Ia 
antigens.  Macrophages are known to be Ia positive (17), relatively radiation- 
resistant (6),  and stimulatory in an MLR (24). Thus,  it is conceivable that Ia 
antigens in AEF are derived either wholly or in part from esterase-negative 
(<1% esterase-positive), irradiated, stimulator splenic macrophages. If this is 
the case, a possible macrophage origin for AEF must then be considered. 
MLR  responder  T  cells  have  been  purported  to  be  Ia  negative  because 
pretreatment of these cells with anti-Ia serum plus complement does not inhibit 
their subsequent MLR response (11,  25). Other studies have shown by immu- 
nofluorescence that the Ly-1  ÷,  23-  subpopulation of MLR responder T blasts, 
during  activation  across  an  /-region  incompatibility,  can  bind  Ia  antigens 
derived from the stimulator haplotype (26). It has also been demonstrated that, 
during an MLR,  the Ly-1  ÷,  23-  subpopulation of responder T  cells recognizes 
allogeneic Ia antigens on stimulator cells (27). Consistent with this finding is 
the report that the elimination of Ly-1  ÷, 23- T cells from the activated responder 
cells used in the generation of a nonrestricted AEF results in the loss of about 
85%  of AEF  helper  activity  (22). Hence,  during  the  in  vitro  production  of 
restricted AEF,  Ia antigens determined by the stimulator haplotype may be 
secreted by the stimulator B cell and may then bind in a specific fashion to an 
Ia-negative responder T cell. This responder T cell would now become Ia positive 
and may then release these Ia antigens, perhaps in combination with another 
Ia-negative component(s), into AEF.  If this sequence of events were to occur, 
AEF Ia antigens would then have to be considered to be B-cell-derived, T-cell- 
dependent, products.  This conclusion would support our hypothesis that AEF 
does indeed have a  B-cell origin. It would also support our previous suggestion 
that Ia antigens found on T-cell membranes are passively adsorbed products 
synthesized by B cells (17). AEF would therefore represent the first Ia-positive 
helper factor to be identified as being a  B-cell product. This line of reasoning 
would also be compatible with a previous claim that AEF is T-cell derived (28). 
Thus,  attempts will be made in the future to determine whether Ia antigens 
controlled by the stimulator haplotype appear on the surface of either untreated 
or anti-Ia plus  complement-treated MLR activated responder T  cells used to 
produce AEF. 
A strain distribution analysis of the capacity of restricted AEF to stimulate a 
secondary anti-DNP PFC response confirmed a  previous expectation (12), that 
this factor can help B cells of only its own haplotype, or of haplotypes which 
express identical Ia antigens. An I-A and/or I-B subregion identity between the 1208  /-REGION  CONTROL  OF  B-CELL  ACTIVATION 
restricted AEF producing strain and the target cell strain was required for this 
response. The responses obtained here are consistent with previous reports that 
the stimulation of an antibody response by a positive allogeneic effect involves 
a  cooperative recognition of I-region products (29). By contrast,/-region prod- 
ucts are not recognized during a  negative allogeneic effect which results from 
the suppression of an immune response by allogeneic T cells (27, 29). 
Thus, the/-subregion determinants which are present in restricted AEF must 
also appear on the surface of its target cell. This suggests that the target cell 
bears a specific receptor for restricted AEF and that this receptor and restricted 
AEF are both products of the same/-subregion(s). Since it has been tentatively 
concluded above that restricted AEF Ia molecules are determined by I-A, this I- 
subregion may also control the receptor postulated to exist here. The suggestion 
that AEF and its receptor are encoded by the I-A subregion would agree closely 
with the previously reported control by this I-subregion of other helper factors 
and their receptors (4-6,  10). 
Studies performed here demonstrate that the B cell represents the target cell 
of AEF.  Furthermore,  they  suggest  that  an  Ia-positive  B  cell  expresses  a 
receptor for AEF. It appears that neither a prior antigen-activation of the B cell 
nor  a  specific surface modulation event is  necessary for the  expression  and 
function of this  receptor.  These  data  therefore strongly  support  the  earlier 
evidence that AEF produced in the usual manner (12,  28) and other antigen- 
nonspecific T-cell replacing factors (30, 31) act directly on B cells during either 
a  primary  IgM  or  a  secondary  IgG  antibody  response.  The  latter  factors 
described both stimulate a  B-cell response which is macrophage independent. 
T  cells  and  macrophages from either unprimed  or  antigen-primed donors 
apparently do not express a receptor for restricted AEF, or otherwise possess a 
substantially lower density of receptors which is below the limit of sensitivity of 
detection achieved here.  These results  differ from those previously obtained 
with  Ia-positive  T-cell-derived suppressor  factors  and  an  Ia-positive  macro- 
phage-derived helper factor, which are purported to possess I-region determined 
receptors on antigen-activated T cells (7, 9) and normal T cells (6), respectively. 
As mentioned above, several in vitro studies of IgG antibody synthesis have 
shown a  requirement for/-region compatibility between several helper factors 
and  their  respective  receptors.  Similarly,  I-region  identity  is  required  for 
effective T-cell B-cell interaction in vivo.  Katz et al.  (32) have reported that 
antigen-primed T and B cells must share an I-A subregion identity to cooperate 
for a secondary IgG antibody response. Press et al. (33) have demonstrated that 
a  secondary IgG anti-DNP response may be mediated by a specific recognition 
by carrier-primed T  cells of syngeneic Ia antigens on hapten-primed B  cells. 
The same conclusion was reached by Pierce and Klinman (34) who showed that 
the  transfer  of primary  DNP-specific  B  cells  into  allogeneic carrier-primed 
recipients resulted in only an IgM anti-DNP response; the transfer of either 
primary or secondary DNP-specific B cells into syngeneic carrier-primed recipi- 
ents resulted in only an IgG response (35). In the latter studies, stimulation of 
IgG production was dependent on an identity in the I-A subregion between the 
collaborating T and B cells. 
The apparent need for I-region compatibility exemplified in vitro in this study 
may  therefore  represent  an  event  of normal  B-cell  activation  during  IgG TERRY  L.  DELOVITCH,  JUDITH  BIGGIN,  AND  FOON-YEE FUNG  1209 
antibody synthesis in vivo. It may be envisaged, as proposed above, that aider 
antigenic stimulation a  T cell recognizes Ia determinants on a  B cell and then 
passively acquires these Ia  molecules onto its  surface.  This  Ia-positive T  cell 
may then interact with a syngeneic antigen-presenting cell, i.e., a macrophage. 
Such an interaction might induce the release from the T cell of the immunizing 
antigen or fragment thereof, Ia antigens,  and perhaps other membrane-associ- 
ated  components.  These  T-cell  released  components,  which  may  or  may not 
become associated in a complex structure, might be recognized and bind to their 
specific receptors on a  B  cell.  Such a  mechanism  would allow for an/-region 
identity to be achieved at both the macrophage T cell and T cell B cell levels of 
interaction.  It would also enable a  T cell to recruit and collaborate with an Ia 
compatible B cell. 
A  two-signal  hypothesis  has  been  proposed  for  B-cell  triggering  (36,  37). 
Antigen  represents  the  first  signal  that  binds  to  its  B-cell immunoglobulin 
receptor.  A  T-cell  factor or thymus-independent  antigen  may act as a  second 
signal  and bind to another  B-cell surface receptor.  AEF,  which consists of Ia 
antigens and perhaps additional Ia-negative components, may mediate T cell B 
cell collaboration by serving as a  second signal given to the B cell during the 
stimulation  of an antibody response.  Hence, a  specific recognition between an 
Ia  molecule in AEF and a  complementary component(s)  in its  B-cell receptor 
could conceivably occur during B-cell activation. 
The  immunochemical  nature  of the  receptor for AEF is not known.  It has 
been  suggested  here  that  this  receptor  is  an  /-region  gene  product.  The 
possibility has also been raised that the receptor for another nonantigen-specific 
mediator  of B-cell responses  bears  Ia  determinants  (38).  However,  it  is  also 
possible that these receptors are not comprised of Ia antigens.  One alternative 
to  be considered  in  the  present  study is  that  Ia  antigens  on the  B  cell  may 
become associated with the receptor for AEF only aider the formation of a factor 
receptor complex.  The receptor may in fact be controlled by a  non-H-2-1inked 
gene.  It may recognize an Ia-negative T-cell-derived component of AEF which 
is  complexed to  an  Ia  molecule.  The/-region  compatibility requirement  dis- 
cussed earlier may be fulfilled solely by the interaction of AEF Ia antigens and 
syngeneic Ia antigens on a  nonreceptor portion of the B-cell membrane.  These 
possibilities may only be analysed by a comparative biochemical analysis of this 
B-cell receptor (if it can be isolated), B-cell surface Ia antigens and Ia antigens 
in AEF.  Such studies are currently in progress. 
Summary 
A  genetically restricted allogeneic effect factor (AEF) derived from a  mixed 
lymphocyte culture reaction between Ia-negative activated responder cells and 
irradiated T-cell-depleted stimulator cells was characterized.  Restricted AEF is 
a  B-cell-derived  soluble  helper  factor  which  consists  in  part  of Ia  antigens 
controlled by the I-A subregion of the stimulator haplotype; additional control 
by the I-B, I.E,  and I-C subregions,  although unlikely, could not be excluded. 
This factor helps B cells of only its own haplotype or of haplotypes which carry 
an I-A  and/or I-B  subregion identity.  Unprimed as well as hapten-primed  Ia- 
positive B cells express a  receptor for restricted AEF. The results indicate that 
the B-cell receptor for AEF is determined by the I-A subregion.  Both restricted 1210  /-REGION  CONTROL OF  B-CELL ACTIVATION 
AEF  and its receptor may therefore be products of  the same/-region gene(s). 
The data are compatible with the hypothesis that  the AEF  la antigens serve as 
a second signal required for B-cell activation to IgG antibody production. 
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